Breaking News Instant updates and real-time market news.

AMZN

Amazon.com

$3,700.86 /

+46.28 (+1.27%)

, BTC

Bitcoin

$0.00 /

+ (+0.00%)

16:59
07/26/21
07/26
16:59
07/26/21
16:59

Bitcoin tumbles after Amazon denies it will accept it as payment, Bloomberg says

Amazon (AMZN) posted a job advertisement for a cryptocurrency and blockchain lead earlier today, but an Amazon spokesperson denied the company would accept the cryptocurrency for payments this year. After surpassing $40,000 briefly on the report that was later denied, Bitcoin fell below $38,000, according to Bloomberg's Joanna Ossinger and Vildana Hajric. Reference Link

AMZN

Amazon.com

$3,700.86 /

+46.28 (+1.27%)

BTC

Bitcoin

$0.00 /

+ (+0.00%)

  • 29

    Jul

AMZN Amazon.com
$3,700.86 /

+46.28 (+1.27%)

07/26/21 Credit Suisse
Amazon.com price target raised to $4,850 from $4,000 at Credit Suisse
07/26/21 Wedbush
Wedbush expects 'Amazon-sized' tailwinds from Prime Day, COVID-19
07/23/21 Morgan Stanley
Snap price target raised to $85 from $75 at Morgan Stanley
07/20/21 William Blair
New partnerships align with BigCommerce open SaaS strategy, says William Blair
BTC Bitcoin
$0.00 /

+ (+0.00%)

04/27/21 Roth Capital
Regulatory credits, bitcoin fuel Tesla Q1 headline beat, says Roth Capital
04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
01/13/21 Standpoint Research
Bitcoin could hit $112,000 this year, says Standpoint Research

TODAY'S FREE FLY STORIES

Hot Stocks
Luckin Coffee files annual report for Fiscal 2020 » 07:42
09/21/21
09/21
07:42
09/21/21
07:42
LKNCY

Luckin Coffee

$1.42 /

+ (+0.00%)

Luckin Coffee announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LKNCY Luckin Coffee
$1.42 /

+ (+0.00%)

LKNCY Luckin Coffee
$1.42 /

+ (+0.00%)

LKNCY Luckin Coffee
$1.42 /

+ (+0.00%)

Recommendations
Penn National selloff has been 'overdone,' says Stifel » 07:41
09/21/21
09/21
07:41
09/21/21
07:41
PENN

Penn National

$73.37 /

-1.2 (-1.61%)

After having recently…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PENN Penn National
$73.37 /

-1.2 (-1.61%)

PENN Penn National
$73.37 /

-1.2 (-1.61%)

09/14/21 Wells Fargo
Penn National initiated with an Equal Weight at Wells Fargo
09/09/21 Macquarie
Score Media downgraded to Neutral from Outperform at Macquarie
09/01/21 Capital One
Gaming and Leisure Properties initiated with an Overweight at Capital One
08/05/21 Stifel
Stifel positive on Penn National's acquisition of theScore
PENN Penn National
$73.37 /

-1.2 (-1.61%)

  • 25
    Sep
PENN Penn National
$73.37 /

-1.2 (-1.61%)

PENN Penn National
$73.37 /

-1.2 (-1.61%)

PENN Penn National
$73.37 /

-1.2 (-1.61%)

Recommendations
First Republic loan growth positioned to 'lead the pack,' says JPMorgan » 07:39
09/21/21
09/21
07:39
09/21/21
07:39
FRC

First Republic

$192.90 /

-7.03 (-3.52%)

JPMorgan analyst Steven…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FRC First Republic
$192.90 /

-7.03 (-3.52%)

FRC First Republic
$192.90 /

-7.03 (-3.52%)

07/14/21 Maxim
First Republic price target raised to $235 from $210 at Maxim
07/14/21 Credit Suisse
First Republic price target raised to $180 from $163 at Credit Suisse
07/14/21 Barclays
First Republic price target raised to $205 from $177 at Barclays
07/13/21 Keefe Bruyette
First Republic price target raised to $225 from $215 at Keefe Bruyette
FRC First Republic
$192.90 /

-7.03 (-3.52%)

  • 10
    Aug
  • 02
    Mar
  • 12
    Nov
FRC First Republic
$192.90 /

-7.03 (-3.52%)

Recommendations
Apple iPhone 13 initial waits extended versus 12 cycle, says Credit Suisse » 07:39
09/21/21
09/21
07:39
09/21/21
07:39
AAPL

Apple

$143.02 /

-2.98 (-2.04%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$143.02 /

-2.98 (-2.04%)

AAPL Apple
$143.02 /

-2.98 (-2.04%)

09/17/21 Jefferies
Snap Q3 revenue estimates too low, says Jefferies
09/15/21 Oppenheimer
Apple's iPhone 13 likely to attract upgraders, says Oppenheimer
09/15/21 Deutsche Bank
Apple iPhone changes 'more incremental than transformative,' says Deutsche Bank
09/15/21 Morgan Stanley
Improved iPhone affordability raises Morgan Stanley confidence in Apple growth
AAPL Apple
$143.02 /

-2.98 (-2.04%)

AAPL Apple
$143.02 /

-2.98 (-2.04%)

AAPL Apple
$143.02 /

-2.98 (-2.04%)

AAPL Apple
$143.02 /

-2.98 (-2.04%)

AAPL Apple
$143.02 /

-2.98 (-2.04%)

Hot Stocks
Rekor Systems announces UDOT pilot deployment of traffic management technology » 07:37
09/21/21
09/21
07:37
09/21/21
07:37
REKR

Rekor Systems

$8.96 /

-0.72 (-7.44%)

Rekor Systems announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REKR Rekor Systems
$8.96 /

-0.72 (-7.44%)

REKR Rekor Systems
$8.96 /

-0.72 (-7.44%)

09/15/21 B. Riley
Rekor Systems price target raised to $14 from $13 at B. Riley
08/17/21 Lake Street
Rekor Systems price target lowered to $17 from $25 at Lake Street
08/17/21 Northland
Rekor Systems price target lowered to $15 from $26 at Northland
08/17/21 B. Riley
Rekor Systems price target lowered to $13 from $17.50 at B. Riley
REKR Rekor Systems
$8.96 /

-0.72 (-7.44%)

  • 05
    Feb
REKR Rekor Systems
$8.96 /

-0.72 (-7.44%)

REKR Rekor Systems
$8.96 /

-0.72 (-7.44%)

REKR Rekor Systems
$8.96 /

-0.72 (-7.44%)

Upgrade
TriplePoint Venture upgraded to Buy from Neutral at Compass Point » 07:37
09/21/21
09/21
07:37
09/21/21
07:37
TPVG

TriplePoint Venture

$15.16 /

-0.05 (-0.33%)

Compass Point analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TPVG TriplePoint Venture
$15.16 /

-0.05 (-0.33%)

07/12/21 Piper Sandler
TriplePoint Venture initiated with an Overweight at Piper Sandler
05/19/21 Oppenheimer
TriplePoint Venture initiated with a Perform at Oppenheimer
11/19/20 JMP Securities
TriplePoint Venture resumed with an Outperform at JMP Securities
Upgrade
South State upgraded to Buy at DA Davidson after relative underperformance » 07:37
09/21/21
09/21
07:37
09/21/21
07:37
SSB

South State

$63.76 /

-1.01 (-1.56%)

, ACBI

Atlantic Capital

$22.42 /

-0.44 (-1.92%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SSB South State
$63.76 /

-1.01 (-1.56%)

ACBI Atlantic Capital
$22.42 /

-0.44 (-1.92%)

SSB South State
$63.76 /

-1.01 (-1.56%)

06:39 Today DA Davidson
South State upgraded to Buy from Neutral at DA Davidson
08/16/21
Fly Intel: Top five analyst downgrades
08/16/21 Stephens
South State downgraded to Equal Weight from Overweight at Stephens
07/27/21 Truist
South State price target lowered to $90 from $100 at Truist
ACBI Atlantic Capital
$22.42 /

-0.44 (-1.92%)

07/27/21 Truist
South State price target lowered to $90 from $100 at Truist
07/27/21 Piper Sandler
Atlantic Capital downgraded to Neutral from Overweight at Piper Sandler
07/26/21 Truist
Atlantic Capital price target lowered to $26.50 from $32 at Truist
07/26/21 Raymond James
Atlantic Capital downgraded to Market Perform from Outperform at Raymond James
SSB South State
$63.76 /

-1.01 (-1.56%)

ACBI Atlantic Capital
$22.42 /

-0.44 (-1.92%)

Hot Stocks
Luckin Coffee announces launch of scheme of arrangement in compliance with RSA » 07:36
09/21/21
09/21
07:36
09/21/21
07:36
LKNCY

Luckin Coffee

$1.42 /

+ (+0.00%)

Luckin Coffee announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LKNCY Luckin Coffee
$1.42 /

+ (+0.00%)

LKNCY Luckin Coffee
$1.42 /

+ (+0.00%)

LKNCY Luckin Coffee
$1.42 /

+ (+0.00%)

Recommendations
ConocoPhillips price target raised to $80 from $74 at Credit Suisse » 07:35
09/21/21
09/21
07:35
09/21/21
07:35
COP

ConocoPhillips

$57.08 /

-1.85 (-3.14%)

, RDS.A

Royal Dutch Shell

$39.50 /

-0.875 (-2.17%)

, RDS.B

Royal Dutch Shell

$38.98 /

-0.72 (-1.81%)

, CXO

Bought by COP

$65.79 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COP ConocoPhillips
$57.08 /

-1.85 (-3.14%)

RDS.A Royal Dutch Shell
$39.50 /

-0.875 (-2.17%)

RDS.B Royal Dutch Shell
$38.98 /

-0.72 (-1.81%)

COP ConocoPhillips
$57.08 /

-1.85 (-3.14%)

07/23/21 Piper Sandler
ConocoPhillips price target raised to $80 from $69 at Piper Sandler
07/15/21 Scotiabank
Scotiabank cuts EOG to Sector Perform, suggests shift to ConocoPhillips
07/15/21 Mizuho
ConocoPhillips price target raised to $86 from $82 at Mizuho
07/01/21 Truist
ConocoPhillips price target raised to $77 from $63 at Truist
RDS.A Royal Dutch Shell
$39.50 /

-0.875 (-2.17%)

09/17/21 JPMorgan
Royal Dutch Shell price target lowered to 2,100 GBp from 2,200 GBp at JPMorgan
09/16/21 Deutsche Bank
Royal Dutch Shell price target lowered to 1,871 GBp at Deutsche Bank
07/30/21 Morgan Stanley
Royal Dutch Shell price target raised to 1,865 GBp at Morgan Stanley
07/23/21 Piper Sandler
Royal Dutch Shell price target raised to $57 from $55 at Piper Sandler
RDS.B Royal Dutch Shell
$38.98 /

-0.72 (-1.81%)

09/17/21 JPMorgan
Royal Dutch Shell price target lowered to 2,100 GBp from 2,200 GBp at JPMorgan
08/02/21 MKM Partners
Royal Dutch Shell price target raised to $76 from $68 at MKM Partners
07/30/21 Morgan Stanley
Royal Dutch Shell price target raised to 1,865 GBp at Morgan Stanley
07/06/21 JPMorgan
Royal Dutch Shell price target raised to 2,200 GBp from 2,000 GBp at JPMorgan
CXO Bought by COP
$65.79 /

+ (+0.00%)

01/14/21 Scotiabank
Scotiabank upgrades ConocoPhillips on 'overwhelmingly positive' deal
11/20/20 Stifel
Concho Resources downgraded to Hold from Buy at Stifel
11/19/20 Scotiabank
Concho Resources price target raised to $65.70 from $43 at Scotiabank
11/17/20 Morgan Stanley
Concho Resources downgraded to Equal Weight at Morgan Stanley
COP ConocoPhillips
$57.08 /

-1.85 (-3.14%)

RDS.A Royal Dutch Shell
$39.50 /

-0.875 (-2.17%)

RDS.B Royal Dutch Shell
$38.98 /

-0.72 (-1.81%)

COP ConocoPhillips
$57.08 /

-1.85 (-3.14%)

RDS.A Royal Dutch Shell
$39.50 /

-0.875 (-2.17%)

RDS.B Royal Dutch Shell
$38.98 /

-0.72 (-1.81%)

RDS.A Royal Dutch Shell
$39.50 /

-0.875 (-2.17%)

RDS.B Royal Dutch Shell
$38.98 /

-0.72 (-1.81%)

COP ConocoPhillips
$57.08 /

-1.85 (-3.14%)

Hot Stocks
Nice partners with Tata Consultancy Services for financial crime solutions » 07:35
09/21/21
09/21
07:35
09/21/21
07:35
NICE

Nice

$283.23 /

-2.15 (-0.75%)

Nice announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NICE Nice
$283.23 /

-2.15 (-0.75%)

NICE Nice
$283.23 /

-2.15 (-0.75%)

09/09/21 JMP Securities
Nice price target raised to $343 from $302 at JMP Securities
08/06/21 Citi
Nice price target raised to $328 from $320 at Citi
07/19/21 Jefferies
Jefferies says Zoom deal could drive short-term weakness in RingCentral and Nice
07/06/21 RBC Capital
Nice upgraded to Outperform on cloud platform growth at RBC
NICE Nice
$283.23 /

-2.15 (-0.75%)

NICE Nice
$283.23 /

-2.15 (-0.75%)

Hot Stocks
Luckin Coffee enters binding term sheet to settle U.S. Securities Class Action » 07:34
09/21/21
09/21
07:34
09/21/21
07:34
LKNCY

Luckin Coffee

$1.42 /

+ (+0.00%)

Luckin Coffee announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LKNCY Luckin Coffee
$1.42 /

+ (+0.00%)

LKNCY Luckin Coffee
$1.42 /

+ (+0.00%)

LKNCY Luckin Coffee
$1.42 /

+ (+0.00%)

Recommendations
Cognyte price target lowered to $32 from $40 at Wedbush » 07:33
09/21/21
09/21
07:33
09/21/21
07:33
CGNT

Cognyte

$24.33 /

-3.84 (-13.63%)

, VRNT

Verint

$43.62 /

-0.78 (-1.76%)

Wedbush analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRNT Verint
$43.62 /

-0.78 (-1.76%)

CGNT Cognyte
$24.33 /

-3.84 (-13.63%)

07/27/21 William Blair
Cognyte initiated with an Outperform at William Blair
07/26/21 William Blair
Cognyte initiated with an Outperform at William Blair
03/05/21
Fly Intel: Top five analyst initiations
03/05/21 Evercore ISI
Cognyte initiated with an Outperform at Evercore ISI
VRNT Verint
$43.62 /

-0.78 (-1.76%)

09/01/21 Cowen
Cowen starts 'customer engagement leader' Verint at Outperform
09/01/21 Cowen
Verint initiated with an Outperform at Cowen
06/02/21
Fly Intel: Top five analyst initiations
06/02/21 Evercore ISI
Evercore ISI starts 'category leader' Verint with an Outperform
CGNT Cognyte
$24.33 /

-3.84 (-13.63%)

VRNT Verint
$43.62 /

-0.78 (-1.76%)

CGNT Cognyte
$24.33 /

-3.84 (-13.63%)

VRNT Verint
$43.62 /

-0.78 (-1.76%)

Hot Stocks
Pacira announces publication of Phase 3 study of EXPAREL » 07:33
09/21/21
09/21
07:33
09/21/21
07:33
PCRX

Pacira

$55.37 /

-0.54 (-0.97%)

Pacira BioSciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PCRX Pacira
$55.37 /

-0.54 (-0.97%)

PCRX Pacira
$55.37 /

-0.54 (-0.97%)

07/26/21
Fly Intel: Top five analyst upgrades
07/26/21 JPMorgan
JPMorgan upgrades Pacira amid recovery in elective procedures
07/26/21 JPMorgan
Pacira upgraded to Overweight from Neutral at JPMorgan
06/23/21 Wedbush
Pacira to expand into Latin America with development deal, says Wedbush
PCRX Pacira
$55.37 /

-0.54 (-0.97%)

PCRX Pacira
$55.37 /

-0.54 (-0.97%)

Hot Stocks
Arbutus Biopharma appoints Lisa Caperelli as VP, investor relations » 07:33
09/21/21
09/21
07:33
09/21/21
07:33
ABUS

Arbutus Biopharma

$4.30 /

-0.03 (-0.69%)

, HRMY

Harmony Biosciences

$37.27 /

+0.44 (+1.19%)

Arbutus Biopharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABUS Arbutus Biopharma
$4.30 /

-0.03 (-0.69%)

HRMY Harmony Biosciences
$37.27 /

+0.44 (+1.19%)

ABUS Arbutus Biopharma
$4.30 /

-0.03 (-0.69%)

06/28/21 JMP Securities
Arbutus EASL updates still support progress in Chronic HBV, says JMP Securities
03/10/21 B. Riley Securities
Arbutus Biopharma price target lowered to $7 from $8 at B. Riley Securities
12/17/20 H.C. Wainwright
Arbutus Biopharma initiated with a Buy at H.C. Wainwright
HRMY Harmony Biosciences
$37.27 /

+0.44 (+1.19%)

03/29/21 Goldman Sachs
Harmony Biosciences upgraded to Buy from Neutral at Goldman Sachs
ABUS Arbutus Biopharma
$4.30 /

-0.03 (-0.69%)

HRMY Harmony Biosciences
$37.27 /

+0.44 (+1.19%)

ABUS Arbutus Biopharma
$4.30 /

-0.03 (-0.69%)

ABUS Arbutus Biopharma
$4.30 /

-0.03 (-0.69%)

Hot Stocks
Tractor Supply and Porter-Cable announce partnership » 07:32
09/21/21
09/21
07:32
09/21/21
07:32
TSCO

Tractor Supply

$205.63 /

-1.6 (-0.77%)

PORTER-CABLE and Tractor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSCO Tractor Supply
$205.63 /

-1.6 (-0.77%)

TSCO Tractor Supply
$205.63 /

-1.6 (-0.77%)

08/03/21
Fly Intel: Top five analyst initiations
08/03/21 Benchmark
Tractor Supply initiated with a Buy at Benchmark
07/20/21 Credit Suisse
Tractor Supply price target raised to $190 from $180 at Credit Suisse
07/19/21 Baird
Tractor Supply post-earnings weakness a buying opportunity, says Baird
TSCO Tractor Supply
$205.63 /

-1.6 (-0.77%)

TSCO Tractor Supply
$205.63 /

-1.6 (-0.77%)

TSCO Tractor Supply
$205.63 /

-1.6 (-0.77%)

Recommendations
Stephens keeps Affirm at Underweight, but would be long into investor forum » 07:32
09/21/21
09/21
07:32
09/21/21
07:32
AFRM

Affirm

$107.71 /

-8.4 (-7.23%)

Stephens analyst Vincent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AFRM Affirm
$107.71 /

-8.4 (-7.23%)

AFRM Affirm
$107.71 /

-8.4 (-7.23%)

09/13/21 Barclays
Affirm price target raised to $140 from $115 at Barclays
09/10/21 BofA
Affirm price target raised to $119 from $82 at BofA
09/10/21 Truist
Affirm price target raised to $150 from $120 at Truist
09/10/21 Morgan Stanley
Affirm price target raised to $140 from $120 at Morgan Stanley
AFRM Affirm
$107.71 /

-8.4 (-7.23%)

  • 13
    Jan
AFRM Affirm
$107.71 /

-8.4 (-7.23%)

AFRM Affirm
$107.71 /

-8.4 (-7.23%)

AFRM Affirm
$107.71 /

-8.4 (-7.23%)

Recommendations
Mirati Therapeutics price target raised to $175 from $160 at Oppenheimer » 07:28
09/21/21
09/21
07:28
09/21/21
07:28
MRTX

Mirati Therapeutics

$177.70 /

+3.94 (+2.27%)

, AMGN

Amgen

$215.17 /

-4.42 (-2.01%)

Oppenheimer analyst Jay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRTX Mirati Therapeutics
$177.70 /

+3.94 (+2.27%)

AMGN Amgen
$215.17 /

-4.42 (-2.01%)

MRTX Mirati Therapeutics
$177.70 /

+3.94 (+2.27%)

09/07/21 JPMorgan
Mirati Therapeutics price target lowered to $203 from $205 at JPMorgan
08/26/21 Morgan Stanley
Mirati Therapeutics initiated with an Equal Weight at Morgan Stanley
08/26/21 Morgan Stanley
Mirati Therapeutics initiated with an Equal Weight at Morgan Stanley
06/04/21 Citi
Mirati Therapeutics upgraded to Buy from Neutral at Citi
AMGN Amgen
$215.17 /

-4.42 (-2.01%)

09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley cuts Amgen to Equal Weight, sees better risk/reward elsewhere
09/07/21 Morgan Stanley
Amgen downgraded to Equal Weight from Overweight at Morgan Stanley
08/12/21 Goldman Sachs
Revolution Medicines downgraded to Neutral from Buy at Goldman Sachs
MRTX Mirati Therapeutics
$177.70 /

+3.94 (+2.27%)

AMGN Amgen
$215.17 /

-4.42 (-2.01%)

  • 28
    Oct
MRTX Mirati Therapeutics
$177.70 /

+3.94 (+2.27%)

AMGN Amgen
$215.17 /

-4.42 (-2.01%)

AMGN Amgen
$215.17 /

-4.42 (-2.01%)

Hot Stocks
AIM ImmunoTech says FDA meeting request 'deemed sufficient' for transfer » 07:26
09/21/21
09/21
07:26
09/21/21
07:26
AIM

AIM ImmunoTech

$1.97 /

-0.05 (-2.48%)

AIM ImmunoTech announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AIM AIM ImmunoTech
$1.97 /

-0.05 (-2.48%)

AIM AIM ImmunoTech
$1.97 /

-0.05 (-2.48%)

Hot Stocks
CynergisTek reports new contracts for privacy consulting » 07:26
09/21/21
09/21
07:26
09/21/21
07:26
CTEK

CynergisTek

$1.87 /

-0.05 (-2.60%)

CynergisTek reports new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTEK CynergisTek
$1.87 /

-0.05 (-2.60%)

CTEK CynergisTek
$1.87 /

-0.05 (-2.60%)

Upgrade
Bath & Body Works upgraded to Buy from Hold at Argus » 07:24
09/21/21
09/21
07:24
09/21/21
07:24
BBWI

Bath & Body Works

$64.52 /

-1.845 (-2.78%)

Argus analyst Taylor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBWI Bath & Body Works
$64.52 /

-1.845 (-2.78%)

BBWI Bath & Body Works
$64.52 /

-1.845 (-2.78%)

07:15 Today Argus
Bath & Body Works upgraded to Buy from Hold at Argus
08/24/21 Citi
Bath & Body Works reinstated with a Buy at Citi
08/19/21 UBS
Bath & Body Works delivered 'very solid' Q2, says UBS
08/18/21 UBS
Bath & Body Works price target lowered to $90 from $111 at UBS
BBWI Bath & Body Works
$64.52 /

-1.845 (-2.78%)

BBWI Bath & Body Works
$64.52 /

-1.845 (-2.78%)

BBWI Bath & Body Works
$64.52 /

-1.845 (-2.78%)

Recommendations
PepsiCo price target raised to $175 from $171 at Guggenheim » 07:22
09/21/21
09/21
07:22
09/21/21
07:22
PEP

PepsiCo

$153.59 /

-0.52 (-0.34%)

, KO

Coca-Cola

$54.06 /

-0.37 (-0.68%)

Guggenheim analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PEP PepsiCo
$153.59 /

-0.52 (-0.34%)

KO Coca-Cola
$54.06 /

-0.37 (-0.68%)

PEP PepsiCo
$153.59 /

-0.52 (-0.34%)

07/14/21
Fly Intel: Top five analyst downgrades
07/14/21 Wells Fargo
PepsiCo price target raised to $160 from $147 at Wells Fargo
07/14/21 Truist
PepsiCo price target raised to $160 from $135 at Truist
07/14/21 Deutsche Bank
PepsiCo price target raised to $154 from $149 at Deutsche Bank
KO Coca-Cola
$54.06 /

-0.37 (-0.68%)

07/22/21 Truist
Coca-Cola price target raised to $65 from $60 at Truist
07/22/21 Deutsche Bank
Coca-Cola price target raised to $60 from $58 at Deutsche Bank
07/22/21 Citi
Coca-Cola price target raised to $60 from $57 at Citi
07/16/21 Jefferies
Coca-Cola price target upped to $59 at Jefferies ahead of expected guidance hike
PEP PepsiCo
$153.59 /

-0.52 (-0.34%)

KO Coca-Cola
$54.06 /

-0.37 (-0.68%)

PEP PepsiCo
$153.59 /

-0.52 (-0.34%)

KO Coca-Cola
$54.06 /

-0.37 (-0.68%)

PEP PepsiCo
$153.59 /

-0.52 (-0.34%)

KO Coca-Cola
$54.06 /

-0.37 (-0.68%)

PEP PepsiCo
$153.59 /

-0.52 (-0.34%)

KO Coca-Cola
$54.06 /

-0.37 (-0.68%)

Hot Stocks
Figure Pay partners with Marqeta on digital banking and, 'buy now, pay later' » 07:21
09/21/21
09/21
07:21
09/21/21
07:21
MQ

Marqeta

$25.89 /

-2.31 (-8.19%)

Marqeta announced it is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MQ Marqeta
$25.89 /

-2.31 (-8.19%)

MQ Marqeta
$25.89 /

-2.31 (-8.19%)

08/19/21 Truist
ValueAct's reported SOTP argument for Fiserv 'doesn't hold water,' says Truist
08/18/21
Fly Intel: Top five analyst initiations
08/18/21 Truist
Truist starts Marqeta at Buy on next-gen vCard solutions success
08/18/21 Truist
Marqeta initiated with a Buy at Truist
  • 09
    Jun
MQ Marqeta
$25.89 /

-2.31 (-8.19%)

MQ Marqeta
$25.89 /

-2.31 (-8.19%)

Recommendations
Opsens price target raised to C$6.00 from C$2.75 at Raymond James » 07:20
09/21/21
09/21
07:20
09/21/21
07:20
OPSSF

Opsens

$2.00 /

-0.06 (-2.91%)

, EW

Edwards Lifesciences

$117.98 /

-1.465 (-1.23%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EW Edwards Lifesciences
$117.98 /

-1.465 (-1.23%)

OPSSF Opsens
$2.00 /

-0.06 (-2.91%)

06/30/21 Stifel
Stifel starts potential takeout candidate Opsens at Buy
06/29/21 Stifel
Opsens initiated with a Buy at Stifel
04/15/21 RBC Capital
Opsens price target raised to C$2.25 from C$2 at RBC Capital
04/08/21 Raymond James
Opsens price target raised to C$2.75 from C$2.50 at Raymond James
EW Edwards Lifesciences
$117.98 /

-1.465 (-1.23%)

09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
07/30/21 Canaccord
Edwards Lifesciences price target raised to $124 from $103 at Canaccord
07/30/21 Jefferies
Edwards Lifesciences price target raised to $130 from $110 at Jefferies
07/30/21 Wells Fargo
Edwards Lifesciences price target raised to $115 from $93 at Wells Fargo
EW Edwards Lifesciences
$117.98 /

-1.465 (-1.23%)

EW Edwards Lifesciences
$117.98 /

-1.465 (-1.23%)

EW Edwards Lifesciences
$117.98 /

-1.465 (-1.23%)

Hot Stocks
Cathie Wood's ARK Investment disclosed purchase of 195K shares of Archer » 07:20
09/21/21
09/21
07:20
09/21/21
07:20
ACHR

Archer

$8.71 /

-0.74 (-7.83%)

Shares of Archer are up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACHR Archer
$8.71 /

-0.74 (-7.83%)

ACHR Archer
$8.71 /

-0.74 (-7.83%)

09/01/21 Benchmark
Atlas Crest Investment initiated with a Buy at Benchmark
ACHR Archer
$8.71 /

-0.74 (-7.83%)

ACHR Archer
$8.71 /

-0.74 (-7.83%)

Initiation
Celtic plc reinstated with a Buy at Canaccord » 07:20
09/21/21
09/21
07:20
09/21/21
07:20
CLTFF

Celtic plc

$1.50 /

+ (+0.00%)

Canaccord analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.